XML 40 R44.htm IDEA: XBRL DOCUMENT v2.4.1.9
Noncontrolling Interests (Narrative) (Details) (USD $)
6 Months Ended 1 Months Ended
Dec. 31, 2014
Dec. 31, 2014
Jul. 02, 2013
Jul. 12, 2013
Jul. 11, 2013
Schedule of Equity Method Investments [Line Items]          
Impairment charge $ 42,931,000us-gaap_AssetImpairmentCharges        
US Cosmeceutechs, LLC [Member]          
Schedule of Equity Method Investments [Line Items]          
Amount of investment     6,000,000us-gaap_EquityMethodInvestmentAggregateCost
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= rden_UsCosmeceutechsLlcMember
   
Collateralized convertible note, interest rate     1.50%us-gaap_DebtInstrumentInterestRateEffectivePercentage
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= rden_UsCosmeceutechsLlcMember
   
Percentage of fully diluted equity interest, investment can convert to     50.00%rden_PercentageOfFullyDilutedEquityInterestInvestmentCanConvertTo
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= rden_UsCosmeceutechsLlcMember
   
Device Company [Member]          
Schedule of Equity Method Investments [Line Items]          
Percentage of equity interest purchased       20.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= rden_DeviceCompanyMember
 
EA USC Subsidiary [Member] | US Cosmeceutechs, LLC [Member]          
Schedule of Equity Method Investments [Line Items]          
Amount of investment         3,600,000us-gaap_EquityMethodInvestmentAggregateCost
/ dei_LegalEntityAxis
= rden_EaUscSubsidiaryMember
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= rden_UsCosmeceutechsLlcMember
Percentage of equity interest purchased         30.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ dei_LegalEntityAxis
= rden_EaUscSubsidiaryMember
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= rden_UsCosmeceutechsLlcMember
Additional investment 2,000,000rden_EquityMethodInvestmentAdditionalAmountInvested
/ dei_LegalEntityAxis
= rden_EaUscSubsidiaryMember
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= rden_UsCosmeceutechsLlcMember
2,000,000rden_EquityMethodInvestmentAdditionalAmountInvested
/ dei_LegalEntityAxis
= rden_EaUscSubsidiaryMember
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= rden_UsCosmeceutechsLlcMember
     
Demand loan included as part of Convertible Note 1,000,000us-gaap_SecuredDemandNotes
/ dei_LegalEntityAxis
= rden_EaUscSubsidiaryMember
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= rden_UsCosmeceutechsLlcMember
1,000,000us-gaap_SecuredDemandNotes
/ dei_LegalEntityAxis
= rden_EaUscSubsidiaryMember
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= rden_UsCosmeceutechsLlcMember
     
Convertible Note, aggregate principal amount $ 9,000,000us-gaap_ConvertibleDebt
/ dei_LegalEntityAxis
= rden_EaUscSubsidiaryMember
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= rden_UsCosmeceutechsLlcMember
$ 9,000,000us-gaap_ConvertibleDebt
/ dei_LegalEntityAxis
= rden_EaUscSubsidiaryMember
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= rden_UsCosmeceutechsLlcMember
     
Percentage of fully diluted equity interests owned once Convertible Note is converted   85.45%rden_PercentageOfFullyDilutedEquityInterestsOwnedUponConversionOfNote
/ dei_LegalEntityAxis
= rden_EaUscSubsidiaryMember
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= rden_UsCosmeceutechsLlcMember
     
Percentage of Members remaining equity interest subject to put and call option   14.55%rden_PercentageOfRemainingEquityInterestSubjectToPutAndCallOption
/ dei_LegalEntityAxis
= rden_EaUscSubsidiaryMember
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= rden_UsCosmeceutechsLlcMember